Kirin Cashes Out of Amgen Drug Joint Venture for $780M Post author:Sam Post published:October 30, 2017 Post category:BioPharma Amgen and Kirin have decided to dissolve their joint venture, Kirin-Amgen. Source: BioSpace You Might Also Like Clovis Expands Bay Area Footprint With Huge Lease in Oakland November 27, 2017 Trading In Novo Nordisk A/S Shares By Board Members, Executives And Associated Persons On 8 May 2017 May 8, 2017 Effective Immediately: Bristol-Myers Squibb Exec to Take the Reins at Kleo June 8, 2017
Trading In Novo Nordisk A/S Shares By Board Members, Executives And Associated Persons On 8 May 2017 May 8, 2017
